{"id":46153,"date":"2022-02-08T14:43:20","date_gmt":"2022-02-08T13:43:20","guid":{"rendered":"https:\/\/www.aiom.it\/?p=46153"},"modified":"2022-02-15T14:48:31","modified_gmt":"2022-02-15T13:48:31","slug":"cabozantinib-for-radioiodine-refractory-differentiated-thyroid-cancer-cosmic-311-a-randomised-double-blind-placebo-controlled-phase-3-trial","status":"publish","type":"post","link":"https:\/\/www.aiom.it\/en\/cabozantinib-for-radioiodine-refractory-differentiated-thyroid-cancer-cosmic-311-a-randomised-double-blind-placebo-controlled-phase-3-trial\/","title":{"rendered":"Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial"},"content":{"rendered":"<p>&nbsp;<\/p>\n<p><em>Marcia S Brose, Bruce Robinson, Steven I Sherman, Jolanta Krajewska, Chia-Chi Lin, Fernanda Vaisman, Ana O Hoff, Erika Hitre, Daniel W Bowles, Jorge Hernando, Leonardo Faoro, Kamalika Banerjee, Jennifer W Oliver, Bhumsuk Keam, Jaume Capdevila <img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-35531\" src=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/01\/The-Lancet-Oncology-223x300.png\" alt=\"\" width=\"223\" height=\"300\" srcset=\"https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/01\/The-Lancet-Oncology-223x300.png 223w, https:\/\/www.aiom.it\/wp-content\/uploads\/2020\/01\/The-Lancet-Oncology.png 572w\" sizes=\"auto, (max-width: 223px) 100vw, 223px\" \/><\/em><\/p>\n<p><em>The Lancet Oncology<\/em>, 2021 Aug<\/p>\n<p style=\"text-align: right;\"><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34237250\/\">Abstract link<\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>Copyright \u00a9 2021 Elsevier Ltd. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; Marcia S Brose, Bruce Robinson, Steven I Sherman, Jolanta Krajewska, Chia-Chi Lin, Fernanda Vaisman, Ana O Hoff, Erika Hitre, Daniel W Bowles, Jorge Hernando, Leonardo Faoro, Kamalika Banerjee, Jennifer W Oliver, Bhumsuk Keam, Jaume Capdevila The Lancet Oncology, 2021 Aug Abstract link &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Copyright \u00a9 2021 Elsevier Ltd. [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":46160,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[255],"tags":[],"class_list":["post-46153","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articoli-scientifici-en"],"_links":{"self":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/46153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/comments?post=46153"}],"version-history":[{"count":2,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/46153\/revisions"}],"predecessor-version":[{"id":46155,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/posts\/46153\/revisions\/46155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media\/46160"}],"wp:attachment":[{"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/media?parent=46153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/categories?post=46153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.aiom.it\/en\/wp-json\/wp\/v2\/tags?post=46153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}